期刊论文详细信息
Frontiers in Immunology
Innate immune response restarts adaptive immune response in tumors
Immunology
Qing-qing Zhang1  Guo-qiang Yuan2  Qiao Li2  Shang-yu Liu2  Ya-wen Pan2  Wen-shan Li3 
[1] Department of Respiratory and Critical Care Medicine, Qinghai University Affiliated Hospital, Xining, Qinghai, China;The Department of Neurosurgery, The Second Hospital of Lanzhou University, Lanzhou, Gansu, China;Key Laboratory of Neurology of Gansu Province, The Second Hospital of Lanzhou University, Lanzhou, Gansu, China;The Department of Neurosurgery, The Second Hospital of Lanzhou University, Lanzhou, Gansu, China;Key Laboratory of Neurology of Gansu Province, The Second Hospital of Lanzhou University, Lanzhou, Gansu, China;Department of Neurosurgery, Qinghai Provincial People’s Hospital, Xining, Qinghai, China;
关键词: DNA sensing;    RNA sensing;    crosstalk;    glioblastoma;    type I interferon;   
DOI  :  10.3389/fimmu.2023.1260705
 received in 2023-07-20, accepted in 2023-08-25,  发布年份 2023
来源: Frontiers
PDF
【 摘 要 】

The imbalance of immune response plays a crucial role in the development of diseases, including glioblastoma. It is essential to comprehend how the innate immune system detects tumors and pathogens. Endosomal and cytoplasmic sensors can identify diverse cancer cell antigens, triggering the production of type I interferon and pro-inflammatory cytokines. This, in turn, stimulates interferon stimulating genes, enhancing the presentation of cancer antigens, and promoting T cell recognition and destruction of cancer cells. While RNA and DNA sensing of tumors and pathogens typically involve different receptors and adapters, their interaction can activate adaptive immune response mechanisms. This review highlights the similarity in RNA and DNA sensing mechanisms in the innate immunity of both tumors and pathogens. The aim is to enhance the anti-tumor innate immune response, identify regions of the tumor that are not responsive to treatment, and explore new targets to improve the response to conventional tumor therapy and immunotherapy.

【 授权许可】

Unknown   
Copyright © 2023 Li, Zhang, Li, Liu, Yuan and Pan

【 预 览 】
附件列表
Files Size Format View
RO202310124099751ZK.pdf 2073KB PDF download
  文献评价指标  
  下载次数:6次 浏览次数:0次